Carbidopa and levodopa and Namenda
Determining the interaction of Carbidopa and levodopa and Namenda and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Memantine may theoretically enhance the pharmacologic effects of dopaminergic agents. The clinical significance is unknown.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Multum Information Services, Inc. Expert Review Panel"
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and levodopa-Namenda (Memantine Solution)
- Carbidopa and levodopa-Namenda (Memantine Tablets)
- Carbidopa and levodopa-Namenda XR
- Carbidopa and levodopa-Namenda XR Titration Pack
- Carbidopa and levodopa-Namzaric
- Carbidopa and levodopa-Namzaric Titration Pack
- Namenda-Carbidopa and levodopa enteral
- Namenda-Carbidopa and Levodopa Enteral Suspension
- Namenda-Carbidopa and Levodopa Extended-Release Capsules
- Namenda-Carbidopa and Levodopa Extended-Release Tablets
- Namenda-Carbidopa and Levodopa ODT
- Namenda-Carbidopa and Levodopa Orally Disintegrating Tablets